During the past decade, Krankenhaus Barmherzige Brüder Regensburg conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Barmherzige Brüder Regensburg" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "German CLL Study Group" with 5 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored and "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Barmherzige Brüder Regensburg" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "German CLL Study Group" with 2 trials as a collaborator, "German Research Foundation" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Barmherzige Brüder Regensburg" are "Chronic Lymphocytic Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Lymphoma" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Krankenhaus Barmherzige Brüder Regensburg" in a lesser frequency.

Most popular intervention types in "Krankenhaus Barmherzige Brüder Regensburg" are "Drug" (30 trials), "Device" (9 trials), "Biological" (8 trials), "Procedure" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "radiation therapy" (4 trials), "Carboplatin" (3 trials), "Cytarabine" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Barmherzige Brüder Regensburg" are 50 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus Barmherzige Brüder Regensburg". undefined are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Krankenhaus Barmherzige Brüder Regensburg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Barmherzige Brüder Regensburg, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".

Krankenhaus Barmherzige Brüder Regensburg has several departments that took part in Clinical trials: "Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie" - 5 trials, "Krankenhaus Barmherziger Brüder; Klinik für Internistische Onkologie / Hämatologie" - 2 trials